Augmedix (OTCMKTS:AUGX) PT Raised to $5.50 at B. Riley

Augmedix (OTCMKTS:AUGX – Get Rating) had its target price hoisted by equities researchers at B. Riley from $5.00 to $5.50 in a research note issued to investors on Monday, The Fly reports. B. Riley’s price target points to a potential upside of 42.86% from the stock’s previous close. A number of other equities research analysts […]

Related Keywords

United States , ,Charles Schwab Investment Management Inc ,Citadel Advisors ,Maxim Group ,Dfpg Investments ,Augmedix Company Profile ,Augmedix Inc ,Get Rating ,Street Corp ,Schwab Investment Management ,Augmedix Live ,Augmedix Notes ,Augmedix Daily ,Augmedix ,Otcmkts Augx ,Augx ,Medical ,Boost Price Target ,B Riley ,